The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology
Speakers' Bureau - Novartis; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Phase 1 multicenter, open-label study to establish the maximum tolerated dose (MTD) of two administration schedules of E7389 (eribulin) liposomal formulation in patients (pts) with solid tumors.
 
Ishtiaq Husain Zubairi
Stock and Other Ownership Interests - GlaxoSmithKline; Roche
 
Emma Jane Dean
Consulting or Advisory Role - Aptus Clinical (Inst); Theradex Ltd
Travel, Accommodations, Expenses - AstraZeneca
 
L Rhoda Molife
Employment - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
 
Juanita Suzanne Lopez
No Relationships to Disclose
 
Malcolm Ranson
No Relationships to Disclose
 
Fatima El-Khouly
No Relationships to Disclose
 
Claudio Isaac Savulsky
Employment - Eisai
 
Larisa Reyderman
Employment - Eisai
Stock and Other Ownership Interests - Bristol-Myers Squibb; Merck
 
Yan Jia
Employment - Eisai
 
Emily Hutton
Employment - Eisai
 
Rosemary Morrison
No Relationships to Disclose
 
Lorna Sweeting
No Relationships to Disclose
 
Alastair Greystoke
No Relationships to Disclose
 
Jorge Barriuso
No Relationships to Disclose
 
Rebecca Sophie Kristeleit
Honoraria - AstraZeneca; Clovis Oncology; Roche/Genentech
Consulting or Advisory Role - Clovis Oncology; Lytix Biopharma; Roche/Genentech; Sotio
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; PiQuR
 
T.R. Jeffry Evans
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Baxter (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Karus Therapeutics (Inst)
Speakers' Bureau - Bristol-Myers Squibb; Celgene
Research Funding - AstraZeneca (Inst); Basilea (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); e-Therapeutics (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Merck (Inst); Roche (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene